HALEY UHRICH: Open Payments
NPI 1396453304 · KEARNEY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$277 in 14 payments from 10 companies in 2025. Trend: 2023 $103 · 2024 $106 · 2025 $277
Food & beverage: $277
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Fresenius USA Marketing, Inc. | 2 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Vifor Pharma, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Travere Therapeutics, Inc. | 1 | $16 |
| ARGENX US, INC. | 1 | $14 |
Products named: EOHILIA, Kerendia, VELPHORO, AUSTEDO XR, Veltassa, CREON, FASENRA, ACTHAR.
Industry payments across NE — which companies pay providers there.
